Cipher Pharmaceuticals Inc.
CPH.TO
TSX
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 2.62M | 3.34M | 283.00K | 3.00M | 4.92M |
| Total Depreciation and Amortization | 1.82M | 1.51M | 1.93M | 292.00K | 289.00K |
| Total Amortization of Deferred Charges | 38.00K | 39.00K | 22.00K | -- | -- |
| Total Other Non-Cash Items | -494.00K | -4.08M | 20.00K | 110.00K | -1.08M |
| Change in Net Operating Assets | 230.00K | 8.07M | -248.00K | 2.83M | -1.70M |
| Cash from Operations | 4.22M | 8.89M | 2.00M | 6.23M | 2.43M |
| Capital Expenditure | -2.00K | -7.00K | -80.02M | -11.00K | -6.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -2.00K | -7.00K | -80.02M | -11.00K | -6.00K |
| Total Debt Issued | -- | 0.00 | 40.00M | -- | -- |
| Total Debt Repaid | -76.00K | -70.00K | -106.00K | -29.00K | -28.00K |
| Issuance of Common Stock | 31.00K | 15.00K | 10.00K | 24.00K | 103.00K |
| Repurchase of Common Stock | -- | 0.00 | 0.00 | 0.00 | -176.00K |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -49.00K | -398.00K | -- | -- |
| Cash from Financing | -45.00K | -104.00K | 39.51M | -5.00K | -101.00K |
| Foreign Exchange rate Adjustments | -10.00K | -461.00K | 52.00K | -206.00K | -171.00K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 4.16M | 8.31M | -38.46M | 6.00M | 2.16M |